Connection

BORJE S ANDERSSON to Flow Cytometry

This is a "connection" page, showing publications BORJE S ANDERSSON has written about Flow Cytometry.
Connection Strength

0.494
  1. Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions. Exp Hematol. 2017 08; 52:65-71.
    View in: PubMed
    Score: 0.372
  2. 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis. Leuk Res. 2010 Mar; 34(3):364-72.
    View in: PubMed
    Score: 0.055
  3. Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica. 2017 01; 102(1):110-117.
    View in: PubMed
    Score: 0.022
  4. KBM-3, an in vitro model of human acute myelomonocytic leukemia. Exp Hematol. 1992 Mar; 20(3):361-7.
    View in: PubMed
    Score: 0.016
  5. Analysis of nuclear m-AMSA content by DNA fluorochrome competition. Eur J Cancer Clin Oncol. 1986 Jul; 22(7):883-9.
    View in: PubMed
    Score: 0.011
  6. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplant. 2006 Mar; 37(6):575-82.
    View in: PubMed
    Score: 0.011
  7. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood. 1992 Aug 01; 80(3):582-6.
    View in: PubMed
    Score: 0.004
  8. Changes in the expression of B cell surface markers on complement receptor-positive and complement receptor-negative B cells induced by phorbol myristate acetate. J Immunol. 1984 Jan; 132(1):235-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.